The association of coffee intake with liver cancer incidence and chronic liver disease mortality in male smokers

[1]  Carlo La Vecchia,et al.  Hepatocellular carcinoma epidemiology. , 2014, Best practice & research. Clinical gastroenterology.

[2]  Lei Dong,et al.  Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway. , 2013, Toxicology.

[3]  Sun-Mee Lee,et al.  Protective effects of chlorogenic acid against ischemia/reperfusion injury in rat liver: molecular evidence of its antioxidant and anti-inflammatory properties. , 2012, The Journal of nutritional biochemistry.

[4]  J. Samet,et al.  Total cholesterol and cancer risk in a large prospective study in Korea. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  Z. Bao,et al.  Coffee consumption and risk of cancers: a meta-analysis of cohort studies , 2011, BMC Cancer.

[6]  Jian-Min Yuan,et al.  Coffee consumption and reduced risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study , 2011, Cancer Causes & Control.

[7]  Mitsuru Sugawara,et al.  In vitro and in vivo antioxidant properties of chlorogenic acid and caffeic acid. , 2011, International journal of pharmaceutics.

[8]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[9]  R. Bataller,et al.  Cigarette smoking and chronic liver diseases , 2010, Gut.

[10]  P. Muriel,et al.  Coffee and liver diseases. , 2010, Fitoterapia.

[11]  J. Hoofnagle,et al.  Increased caffeine consumption is associated with reduced hepatic fibrosis , 2010, Hepatology.

[12]  M. Woodward,et al.  Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. , 2009, Archives of internal medicine.

[13]  C. la Vecchia,et al.  Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. , 2009, Cancer letters.

[14]  R. Hayes,et al.  Prediagnostic Total and High-Density Lipoprotein Cholesterol and Risk of Cancer , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[15]  William M. Lee,et al.  Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C , 2009, Hepatology.

[16]  C. Bosetti,et al.  Coffee drinking and hepatocellular carcinoma: An update , 2009, Hepatology.

[17]  G. Farrell,et al.  Prevention of hepatocellular carcinoma in nonviral‐related liver diseases , 2009, Journal of gastroenterology and hepatology.

[18]  J. Shearer,et al.  Coffee, glucose homeostasis, and insulin resistance: physiological mechanisms and mediators. , 2008, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[19]  E. Vartiainen,et al.  Joint effects of coffee consumption and serum gamma‐glutamyltransferase on the risk of liver cancer , 2008, Hepatology.

[20]  C. la Vecchia,et al.  Coffee drinking and hepatocellular carcinoma risk: A meta‐analysis , 2007, Hepatology.

[21]  H. El‐Serag,et al.  Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.

[22]  S. Larsson,et al.  Coffee consumption and risk of liver cancer: a meta-analysis. , 2007, Gastroenterology.

[23]  Antonella Afeltra,et al.  Diabetes in chronic liver disease: from old concepts to new evidence , 2006, Diabetes/metabolism research and reviews.

[24]  G. Friedman,et al.  Coffee, cirrhosis, and transaminase enzymes. , 2006, Archives of internal medicine.

[25]  H. El‐Serag,et al.  The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[26]  D. Grobbee,et al.  Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials , 2005, Journal of hypertension.

[27]  H. Glatt,et al.  Coffee diterpenes prevent the genotoxic effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and N-nitrosodimethylamine in a human derived liver cell line (HepG2). , 2005, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[28]  S. Kono,et al.  Coffee consumption and glucose tolerance status in middle-aged Japanese men , 2004, Diabetologia.

[29]  L. Bouter,et al.  Coffee consumption and incidence of impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes: the Hoorn Study , 2004, Diabetologia.

[30]  K. Mochida,et al.  In vitro antioxidative effects and tyrosinase inhibitory activities of seven hydroxycinnamoyl derivatives in green coffee beans. , 2004, Journal of agricultural and food chemistry.

[31]  A. Ahlbom,et al.  Coffee consumption, type 2 diabetes and impaired glucose tolerance in Swedish men and women , 2004, Journal of internal medicine.

[32]  Frank Hu,et al.  Coffee Consumption and Risk for Type 2 Diabetes Mellitus , 2004, Annals of Internal Medicine.

[33]  A. Tverdal,et al.  Coffee intake and mortality from liver cirrhosis. , 2003, Annals of epidemiology.

[34]  A. Constable,et al.  Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[35]  R. Schulte‐Hermann,et al.  Enhancement of the chemoprotective enzymes glucuronosyl transferase and glutathione transferase in specific organs of the rat by the coffee components kahweol and cafestol , 2002, Archives of Toxicology.

[36]  D. Albanes,et al.  The Finnish Cancer Registry as Follow-Up Source of a Large Trial Cohort , 2002, Acta oncologica.

[37]  J. Fraumeni,et al.  International trends and patterns of primary liver cancer , 2001, International journal of cancer.

[38]  P. Whelton,et al.  Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. , 2001, American journal of epidemiology.

[39]  A. Constable,et al.  The coffee-specific diterpenes cafestol and kahweol protect against aflatoxin B1-induced genotoxicity through a dual mechanism. , 1998, Carcinogenesis.

[40]  K. Tanaka,et al.  Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers. , 1998, International journal of epidemiology.

[41]  G. Steil,et al.  Physiological insulinemia acutely modulates plasma leptin. , 1998, Diabetes.

[42]  E. Vartiainen,et al.  Determinants of gamma-glutamyltransferase: positive interaction with alcohol and body mass index, negative association with coffee. , 1997, American journal of epidemiology.

[43]  A. Huggett,et al.  Analysis of the content of the diterpenes cafestol and kahweol in coffee brews. , 1997, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[44]  L. Barbara,et al.  Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis. , 1997, Archives of internal medicine.

[45]  M. Katan,et al.  Levels of the cholesterol-elevating diterpenes cafestol and kahweol in various coffee brews , 1995 .

[46]  S. Kono,et al.  Coffee and serum gamma-glutamyltransferase: a study of self-defense officials in Japan. , 1994, American journal of epidemiology.

[47]  W. Ratnayake,et al.  Lipid content and composition of coffee brews prepared by different methods. , 1993, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[48]  J. Palmgren,et al.  Reproducibility and validity of dietary assessment instruments. I. A self-administered food use questionnaire with a portion size picture booklet. , 1988, American journal of epidemiology.

[49]  E. Arnesen,et al.  The Tromsø Heart Study: distribution of, and determinants for, gamma-glutamyltransferase in a free-living population. , 1986, Scandinavian journal of clinical and laboratory investigation.

[50]  Coffee Drinking , 1891, Hall's journal of health.

[51]  M. F. M. Diniz,et al.  Metabolic syndrome and risk factors for non-alcoholic fatty liver disease. , 2012, Arquivos de gastroenterologia.

[52]  J. Samet,et al.  Total cholesterol and cancer risk in a large prospective study in Korea , 2010 .

[53]  J. Everhart,et al.  Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. , 2005, Gastroenterology.

[54]  Bob Martens,et al.  Analysis of Content , 2002 .

[55]  R. Schulte‐Hermann,et al.  The coffee components kahweol and cafestol induce γ-glutamylcysteine synthetase, the rate limiting enzyme of chemoprotective glutathione synthesis, in several organs of the rat , 2001, Archives of Toxicology.

[56]  K. Suzuki,et al.  Effects of coffee consumption against the development of liver dysfunction: a 4-year follow-up study of middle-aged Japanese male office workers. , 2000, Industrial health.

[57]  The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group. , 1994, Annals of epidemiology.

[58]  J. Fraumeni,et al.  Design, Methods, Participant Characteristics, and Compliance , 1993 .